Facebook Pixel Code
About Sickkids
About SickKids

Melinda Solomon, MD, FRCP(C)

The Hospital for Sick Children
Medical Director, Lung Transplant Program
Respiratory Medicine

Director, Cystic Fibrosis Clinic
Respiratory Medicine

Director, Training Program
Respiratory Medicine

University of Toronto
Associate Professor
Department of Paediatrics

Phone: 416-813-6248
Fax: 416-813-6246
Email: melinda.solomon@sickkids.ca

Brief Biography

Dr. Melinda Solomon completed medical school at the University of Toronto in 1993. She then went on to complete a Paediatric Respirology Fellowship at the Hospital for Sick Children. Following this, Dr. Solomon was appointed a staff physician at SickKids. She then completed postdoctoral training in Paediatric Lung Transplantation at the Children's Hospital of Pittsburg in 2000. In 2003, she became the Medical Director of the Paediatric Lung Transplant Program, caring for both pre-and-post transplant patients. 

Dr. Solomon became the Director of the Cystic Fibrosis Clinic at SickKids in 2005. Her role includes facilitating teacher of Cystic Fibrosis and its complication to patient families, trainees and other healthcare professionals. As a staff physician in the Division of Respiratory Medicine, Dr. Solomon is also a committed clinician in the Chest clinic.  

Education Background

  • BSc, University of Western Ontario, 1989
  • MD, University of Toronto, 1993
  • FRCPC, Paediatrics, Royal College of Physicians and Surgeons of Canada, 1997
  • FRCPC, Paediatric Respirology, Royal College of Physicians and Surgeons of Canada, 1999

Research Interests

Cystic Fibrosis Lung Disease, Lung Transplantation 

External Funding

  • Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (PUSH): Summary for CF Care Providers.  Cystic Fibrosis Foundation, NIH. (Co-Investigator). 2008-2013
  • Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease. Inspire Pharmaceuticals Inc. (Co-Investigator).  2009 - present
  • Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients with Cystic Fibrosis and  Pseudomonas aeruginosa Airway Infection Who Have Limited Treatment. Gilead Sciences. (Co-investigator). 2010-present